Late Breaking Abstract - HRQol and other health related variables of Spanish COPD patients Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician Year: 2020
Estimating severe asthma prevalence in austria using nationwide prescription data Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015
Understanding inequalities in COPD prevention and care policies across Europe Source: International Congress 2015 – Best abstracts in COPD management Year: 2015
Assessment of public awareness on COPD in Singapore in a one-day awareness campaign Source: International Congress 2016 – Public health related concerns and epidemiology of smoking and smoking-related products Year: 2016
Health care costs associated with acute asthma: a economic analysis Source: Eur Respir J 2002; 20: Suppl. 38, 42s Year: 2002
Late Breaking Abstract - Reimbursement for asthma care is a universal barrier to achieving asthma symptom control: the SABINA III study Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020
Late Breaking Abstract - Financial burden of ILD – a claims data based study Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017
External validation of exacerbation and mortality outcomes of health economic decision models for COPD Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016
Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET Source: ERJ Open Res, 7 (3) 00242-2021; 10.1183/23120541.00242-2021 Year: 2021
Late Breaking Abstract - The socio-economic cost of asthma, COPD and chronic bronchitis in Europe. Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017
Reduction in asthma admissions during the COVID-19 pandemic: consequence of public health measures in Singapore Source: Eur Respir J, 57 (4) 2004493; 10.1183/13993003.04493-2020 Year: 2021
COPD admissions and inhaled medications: Escalating prescription costs but no evidence of effect. A national primary care study Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013
Predictive value of annual costs on 3-year mortality in COPD Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes Year: 2015
Aetiology and trends in healthcare workers' occupational asthma Source: Annual Congress 2013 –Occupational respiratory diseases: asthma, silicosis and asbestosis Year: 2013
The economic burden of COPD in a Swedish cohort: The ARCTIC study Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care Year: 2016
Current and future costs of COPD in the Netherlands Source: Annual Congress 2013 –Health economics of airway diseases Year: 2013
Cost of health care associated with workplace exacerbation of asthma Source: Eur Respir J 2007; 30: Suppl. 51, 157s Year: 2007
Effectiveness of montelukast on asthma control in infants: A claims data study Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015
Exploring associations between socio-economic status in the health care access and quality of life of patients with COPD Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013
Modeling future COPD epidemiology Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016